Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$172 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
3.9
Industry P/E
--
EV/EBITDA
1.9
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-4.4
Face value
--
Shares outstanding
12,432,854
CFO
$-190.94 Mln
EBITDA
$-199.94 Mln
Net Profit
$-294.07 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Forte Biosciences (FBRX)
| -6.2 | -15.4 | -6.2 | 244.3 | 0.4 | -49.8 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Forte Biosciences (FBRX)
| 20.1 | 10.4 | -17.8 | -53.3 | -94.1 | 355.2 | -93.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Forte Biosciences (FBRX)
|
25.6 | 172.1 | 0.0 | -51.7 | -138,263.2 | -84.5 | -- | 3.9 |
| 61.0 | 8,072.9 | 1,091.0 | 202.3 | 31.6 | 31.3 | 36 | 14.2 | |
| 229.3 | 13,405.2 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 66.7 | 7,755.6 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 43.9 | 11,247.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.9 | 5.0 | |
| 93.8 | 11,306.9 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 546.9 | 11,592.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 498.3 | 13,063.9 | 2,530.2 | 451.1 | 21.3 | 70.2 | 30.1 | 28.0 | |
| 105.4 | 7,603.8 | 0.0 | -425.4 | -- | -36.7 | -- | 6.0 | |
| 310.4 | 7,699.1 | 0.0 | -303.3 | -- | -45.8 | -- | 8.8 |
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and... autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Address: 3060 Pegasus Park Drive, Dallas, TX, United States, 75247 Read more
CEO, President & Chairman
Dr. Paul A. Wagner Ph.D.
CEO, President & Chairman
Dr. Paul A. Wagner Ph.D.
Headquarters
Dallas, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Forte Biosciences Inc (FBRX) is $25.58 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Forte Biosciences Inc (FBRX) has given a return of 0.43% in the last 3 years.
Since, TTM earnings of Forte Biosciences Inc (FBRX) is negative, P/E ratio is not available.
The P/B ratio of Forte Biosciences Inc (FBRX) is 3.92 times as on 31-Mar-2026, a 2 discount to its peers’ median range of 3.98 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-4.09
|
2.77
|
|
2023
|
-0.95
|
0.85
|
|
2022
|
-0.06
|
0.02
|
|
2021
|
-0.06
|
0.03
|
|
2020
|
-0.40
|
0.32
|
The 52-week high and low of Forte Biosciences Inc (FBRX) are Rs 35.62 and Rs 4.91 as of 05-Apr-2026.
Forte Biosciences Inc (FBRX) has a market capitalisation of $ 172 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Forte Biosciences Inc (FBRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.72
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.